Predicting the intervention threshold for initiating osteoporosis treatment among postmenopausal women in China: a cost-effectiveness analysis based on real-world data

被引：0
|
作者：
L. Cui
T. He
Y. Jiang
M. Li
O. Wang
R. Jiajue
Y. Chi
Q. Xu
X. Xing
W. Xia
机构：
[1] Chinese Academy of Medical Sciences,Department of Endocrinology, Key Laboratory of Endocrinology, Ministry of Health, Peking Union Medical College Hospital
[2] Chinese Academy of Medical Sciences,Department of Hematology, Peking Union Medical College Hospital
[3] Beijing Jishuitan Hospital,Department of Orthopedics
来源：
Osteoporosis International | 2020年 / 31卷
关键词：
Chinese; cost-effectiveness; FRAX; Markov; osteoporosis; zoledronate;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：307 / 316
页数：9
相关论文
共 50 条
  • [31] Crizotinib versus chemotherapy: a real-world cost-effectiveness study in China
    Huang, Meijuan
    Tian, Yuke
    He, Mingmin
    Liu, Juan
    Ren, Li
    Gong, Youling
    Peng, Feng
    Wang, Yongsheng
    Ding, Zhenyu
    Wang, Jin
    Zhu, Jiang
    Xu, Yong
    Liu, Yongmei
    Li, Lanting
    Lu, You
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2020, 9 (02) : 93 - 102
  • [32] A COST-EFFECTIVENESS ANALYSIS OF OSTEOPOROSIS TREATMENT FOR FRACTURE PREVENTION IN POSTMENOPAUSAL THAI WOMEN: A COMPARISON OF SEVEN TREATMENT OPTIONS
    Pongchaiyakul, C.
    Songpattanasilp, T.
    Taechakraichana, N.
    VALUE IN HEALTH, 2010, 13 (07) : A558 - A558
  • [33] Cost-effectiveness analyses using real-world data: an overview of the literature
    Bowrin, Kevin
    Briere, Jean-Baptiste
    Levy, Pierre
    Millier, Aurelie
    Clay, Emilie
    Toumi, Mondher
    JOURNAL OF MEDICAL ECONOMICS, 2019, 22 (06) : 545 - 553
  • [34] Cost-effectiveness of romosozumab for the treatment of postmenopausal women with osteoporosis at high risk of fracture in Belgium
    Gielen, Evelien
    Aldven, Martina
    Kanis, John A.
    Borgstrom, Fredrik
    Senior, Emmanuelle
    Willems, Damon
    OSTEOPOROSIS INTERNATIONAL, 2024, 35 (07) : 1173 - 1183
  • [35] Cost-Effectiveness of Intervention Thresholds for the Treatment of Osteoporosis Based on FRAX® in Portugal
    Andréa Marques
    Óscar Lourenço
    Gustaf Ortsäter
    Fredrik Borgström
    John A. Kanis
    José António P. da Silva
    Calcified Tissue International, 2016, 99 : 131 - 141
  • [36] Cost-Effectiveness of Intervention Thresholds for the Treatment of Osteoporosis Based on FRAX® in Portugal
    Marques, Andrea
    Lourenco, Oscar
    Ortsater, Gustaf
    Borgstrom, Fredrik
    Kanis, John A.
    da Silva, Jose Antnio P.
    CALCIFIED TISSUE INTERNATIONAL, 2016, 99 (02) : 131 - 141
  • [37] Statin Cost-Effectiveness Comparisons Using Real-World Effectiveness Data: Formulary Implications
    Ohsfeldt, Robert L.
    Gandhi, Sanjay K.
    Fox, Kathleen M.
    McKenney, James M.
    VALUE IN HEALTH, 2008, 11 (07) : 1061 - 1069
  • [38] Cost and cost-effectiveness of a real-world HCV treatment program among HIV-infected individuals in Myanmar
    Marquez, Lara K.
    Chaillon, Antoine
    Soe, Kyi Pyar
    Johnson, Derek C.
    Zosso, Jean-Marc
    Incerti, Andrea
    Loarec, Anne
    Nguyen, Aude
    Walker, Josephine G.
    Mafirakureva, Nyashadzaishe
    Lo Re III, Vincent
    Wynn, Adriane
    McIntosh, Craig
    Kiene, Susan M.
    Brodine, Stephanie
    Garfein, Richard S.
    Vickerman, Peter
    Martin, Natasha K.
    BMJ GLOBAL HEALTH, 2021, 6 (02):
  • [39] COST-EFFECTIVENESS OF A COMPREHENSIVE HBV SCREENING AND MANAGEMENT PROGRAM IN CHINA: A REAL-WORLD DATA ANALYSIS FROM HUAZHOU CITY
    Wu, S.
    Zhao, W.
    Peng, X.
    VALUE IN HEALTH, 2024, 27 (12)
  • [40] Effectiveness of denosumab for fracture prevention in real-world postmenopausal women with osteoporosis: a retrospective cohort study
    Lai, E. C-C
    Lin, T-C
    Lange, J. L.
    Chen, L.
    Wong, I. C. K.
    Sing, C-W
    Cheung, C-L
    Shao, S-C
    Yang, Y-H Kao
    OSTEOPOROSIS INTERNATIONAL, 2022, 33 (05) : 1155 - 1164
12345